Unknown

Dataset Information

0

Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study.


ABSTRACT:

Objective

To assess the risk of pulmonary embolism, ischaemic stroke, and myocardial infarction associated with combined oral contraceptives according to dose of oestrogen (ethinylestradiol) and progestogen.

Design

Observational cohort study.

Setting

Data from the French national health insurance database linked with data from the French national hospital discharge database.

Participants

4?945?088 women aged 15-49 years, living in France, with at least one reimbursement for oral contraceptives and no previous hospital admission for cancer, pulmonary embolism, ischaemic stroke, or myocardial infarction, between July 2010 and September 2012.

Main outcome measures

Relative and absolute risks of first pulmonary embolism, ischaemic stroke, and myocardial infarction.

Results

The cohort generated 5?443?916 women years of oral contraceptive use, and 3253 events were observed: 1800 pulmonary embolisms (33 per 100?000 women years), 1046 ischaemic strokes (19 per 100?000 women years), and 407 myocardial infarctions (7 per 100?000 women years). After adjustment for progestogen and risk factors, the relative risks for women using low dose oestrogen (20 µg v 30-40 µg) were 0.75 (95% confidence interval 0.67 to 0.85) for pulmonary embolism, 0.82 (0.70 to 0.96) for ischaemic stroke, and 0.56 (0.39 to 0.79) for myocardial infarction. After adjustment for oestrogen dose and risk factors, desogestrel and gestodene were associated with statistically significantly higher relative risks for pulmonary embolism (2.16, 1.93 to 2.41 and 1.63, 1.34 to 1.97, respectively) compared with levonorgestrel. Levonorgestrel combined with 20 µg oestrogen was associated with a statistically significantly lower risk than levonorgestrel with 30-40 µg oestrogen for each of the three serious adverse events.

Conclusions

For the same dose of oestrogen, desogestrel and gestodene were associated with statistically significantly higher risks of pulmonary embolism but not arterial thromboembolism compared with levonorgestrel. For the same type of progestogen, an oestrogen dose of 20 µg versus 30-40 µg was associated with lower risks of pulmonary embolism, ischaemic stroke, and myocardial infarction.

SUBMITTER: Weill A 

PROVIDER: S-EPMC4862376 | biostudies-literature | 2016 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study.

Weill Alain A   Dalichampt Marie M   Raguideau Fanny F   Ricordeau Philippe P   Blotière Pierre-Olivier PO   Rudant Jérémie J   Alla François F   Zureik Mahmoud M  

BMJ (Clinical research ed.) 20160510


<h4>Objective</h4>To assess the risk of pulmonary embolism, ischaemic stroke, and myocardial infarction associated with combined oral contraceptives according to dose of oestrogen (ethinylestradiol) and progestogen.<h4>Design</h4>Observational cohort study.<h4>Setting</h4>Data from the French national health insurance database linked with data from the French national hospital discharge database.<h4>Participants</h4>4 945 088 women aged 15-49 years, living in France, with at least one reimbursem  ...[more]

Similar Datasets

| S-EPMC3708660 | biostudies-literature
| S-EPMC10074551 | biostudies-literature
| S-EPMC7223456 | biostudies-literature
| S-EPMC7933193 | biostudies-literature
| S-EPMC8453402 | biostudies-literature
| S-EPMC3002912 | biostudies-literature
| S-EPMC10868847 | biostudies-literature
| S-EPMC10520333 | biostudies-literature